Ascendis Pharma A/S
USD267.36
+3.66 (+1.39%)
CEO
Jan Moller Mikkelsen
IPO Date
2015-01-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
DK
Open
$265.00
Prev. Close
$263.70
Day Low
$262.76
Day High
$267.98
52W Low
$160.86
52W High
$271.89
Market Cap
$16.61B
Volume
0.08M
| -20.4 |
| 31 Dec 2023 | FY | 83.4% | -180.5% | 330.4% | -58.3% | -5.10 | 0.95 | -13.3 |
| 31 Dec 2022 | FY | 76.3% | -1139.6% | -221.5% | -53.5% | 2.35 | 1.29 | -11.0 |
| 31 Dec 2021 | FY | 54.7% | -4931.6% | -43.4% | -35.4% | 0.24 | 8.03 | -16.9 |
| 31 Dec 2020 | FY | 100.0% | -6025.5% | -50.0% | -42.8% | 0.11 | 14.02 | -16.5 |
| 31 Dec 2019 | FY | 100.0% | -1630.0% | -36.5% | -32.2% | 0.06 | 12.74 | -26.5 |
| 31 Dec 2018 | FY | 100.0% | -1229.5% | -46.5% | -40.8% | 0.00 | 7.53 | -17.3 |
| 31 Dec 2017 | FY | 100.0% | -8097.8% | -66.2% | -58.7% | 0.00 | 8.61 | -9.0 |
| 31 Dec 2016 | FY | 100.0% | -1487.3% | -38.8% | -36.0% | 0.00 | 13.67 | -7.5 |
| -83.8 |
| 30 Sept 2025 | Q3 | 89.5% | -28.5% | 35.0% | -5.3% | -4.67 | 1.03 | -42.3 |
| 30 Jun 2025 | Q2 | 80.1% | -24.6% | 20.7% | -3.6% | -4.23 | 1.02 | -57.0 |
| 31 Mar 2025 | Q1 | 82.6% | -93.7% | 49.9% | -8.9% | -4.46 | 1.04 | -22.8 |
| 31 Dec 2024 | Q4 | 91.9% | -22.1% | 36.4% | -3.3% | -8.10 | 1.17 | -51.7 |
| 30 Sept 2024 | Q3 | 80.6% | -171.5% | 101.9% | -9.1% | -8.10 | 1.16 | -19.8 |
| 30 Jun 2024 | Q2 | 68.2% | -303.9% | 34.1% | -14.4% | -2.09 | 0.74 | -16.4 |
| 31 Mar 2024 | Q1 | 92.1% | -136.6% | 55.0% | -16.3% | -2.81 | 0.83 | -15.3 |
| 31 Dec 2023 | Q4 | 85.9% | -63.1% | 59.6% | -10.5% | -5.10 | 0.95 | -18.6 |